Is SCHC a Buy? What to Consider in 2026
Last updated July 2026
Short answer
The case for SCHC is simple: low-cost, diversified exposure to FTSE Developed Small Cap ex US Liquid Index at a 0.06% expense ratio, anchored by names like ATZ, HBM, ACLN. If that is the exposure you want and you do not already own most of it through another fund, SCHC is a strong core holding. The catch is concentration in its top names and overlap with broad-market funds you may already hold. Whether it is a buy comes down to whether you want FTSE Developed Small Cap ex US Liquid Index and at what cost. Not a recommendation; Walnut is not an investment adviser.
What are you buying with SCHC?
SCHC tracks the FTSE Developed Small Cap ex US Liquid Index, holding thousands of smaller companies across Europe, Japan, Canada, and Asia-Pacific at a 0.06% expense ratio. The key nuance versus a U.S. small-cap fund is geography: SCHC deliberately excludes American companies and adds currency exposure, making it a complement rather than a substitute.
Largest holdings (approximate as of mid-2026; verify on Schwab Asset Management's fund page):
| Rank | Ticker | Company | % of SCHC | |
|---|---|---|---|---|
| 1 | ATZ | Aritzia Inc. | ~0.4% | |
| 2 | HBM | Hudbay Minerals Inc. | ~0.4% | |
| 3 | ACLN | Accelleron Industries AG | ~0.4% | |
| 4 | FTT | Finning International Inc. | ~0.4% | |
| 5 | GAW | Games Workshop Group PLC | ~0.4% | |
| 6 | NKT | NKT A/S | ~0.3% | |
| 7 | IGG | IG Group Holdings plc | ~0.3% | |
| 8 | GTT | Gaztransport & Technigaz SA | ~0.3% | |
| 9 | CPX | Capital Power Corporation | ~0.3% | |
| 10 | N/A | MSCI EAFE index futures (cash equitization sleeve) | ~0.7% |
What's the case for SCHC?
SCHC is a passive ETF from Schwab Asset Management that holds thousands of small-cap stocks in developed markets outside the United States, tracking the FTSE Developed Small Cap ex US Liquid Index. It gives inexpensive, diversified exposure to smaller companies across Europe, Japan, Canada, and the Asia-Pacific region in one ticker, at a 0.06% expense ratio. It is often compared to Vanguard's VSS and typically carries a higher dividend yield than U.S. small-cap funds because foreign companies tend to pay more.
In its favour: it gives you FTSE Developed Small Cap ex US Liquid Index exposure in one ticker at a 0.06% expense ratio, which is simple to hold and cheap to own.
What should you weigh before buying SCHC?
- Cost vs alternatives: 0.06% is the fee; compare it to funds tracking a similar index.
- Concentration: check how much of SCHC sits in its largest holdings (ATZ, HBM, ACLN).
- Overlap: if you already own a broad-market fund, you may already hold much of this.
- Tracking scope: SCHC only gives you FTSE Developed Small Cap ex US Liquid Index; it will not capture what sits outside that index.
How do you decide if SCHC is a buy?
The useful question is rarely “will SCHC go up?” It is “does this exposure fit my plan, at a cost I am happy with, without doubling up on what I already own?” Walnut connects your real brokerage so you can see exactly how SCHC would overlap with your current holdings, analyze it by chatting through Claude or ChatGPT, and place any trade yourself. You stay in control.
The bottom line on SCHC
The bottom line: SCHC is a low-cost core building block for FTSE Developed Small Cap ex US Liquid Index exposure, not a tactical bet on a single name. If you want FTSE Developed Small Cap ex US Liquid Index exposure and the 0.06% fee is competitive for you, it does its job well. If you already own that exposure through another fund, adding it mostly doubles a fee without adding diversification. Decide from your goal and your existing holdings, not from where the market sat last week. Walnut is not an investment adviser.
Build a portfolio around SCHC with Walnut
Use SCHC as your core holding, then let Walnut's AI propose thematic satellites: AI infrastructure, dividend growth, clean energy, whatever you believe in. Connect your broker, build the basket in conversation, track it as one unit.
FAQ
Is SCHC a good ETF to buy?
+
Walnut is informational, not investment advice. Whether SCHC fits depends on your goals, time horizon, and what you already hold. It tracks FTSE Developed Small Cap ex US Liquid Index at a 0.06% expense ratio, so the questions that matter are whether you want that exposure, whether you already own it through another fund, and whether the cost is competitive for what it does.
What does SCHC actually hold?
+
SCHC tracks FTSE Developed Small Cap ex US Liquid Index. Its largest positions include ATZ, HBM, ACLN, FTT, GAW and others (approximate, verify on Schwab Asset Management's fund page). The holdings are what you are really buying, not the ticker.
What is SCHC's expense ratio?
+
0.06% as of mid-2026. Over decades, the expense ratio is one of the few things you can control, so it is worth comparing against close alternatives that track a similar index.
Does SCHC pay a dividend?
+
SCHC distributes a dividend with an approximate yield of ~3.5% (mid-2026). See the SCHC dividend page for how distributions work. Verify the current figure with Schwab Asset Management.
What are the risks of buying SCHC?
+
Like any index ETF, weigh concentration (how much sits in the top holdings), overlap with funds you already own, and whether FTSE Developed Small Cap ex US Liquid Index matches the exposure you actually want. SCHC only gives you FTSE Developed Small Cap ex US Liquid Index, not what sits outside it.
How do I decide if SCHC is right for me?
+
Start from your goal, then check four things: what SCHC holds, its cost versus alternatives, how much it overlaps with what you already own, and whether the exposure fits your time horizon and risk tolerance. Walnut can analyze the overlap against your real holdings; you keep your broker and approve any trade.
Walnut is informational, not investment advice. Figures are approximations stamped to mid-2026; verify current data with Schwab Asset Management or your broker. Nothing here is a recommendation to buy, sell, or hold any security.